Form 8-K - Current report:
SEC Accession No. 0001193805-24-001257
Filing Date
2024-10-22
Accepted
2024-10-22 06:45:28
Documents
32
Period of Report
2024-10-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e663960_8k-immunic.htm   iXBRL 8-K 21462
2 e663960_ex99-1.htm EX-99.1 19952
3 e663960_ex99-2.htm EX-99.2 11867
7 GRAPHIC image1.jpg GRAPHIC 4723
8 GRAPHIC slide1.jpg GRAPHIC 174052
9 GRAPHIC slide2.jpg GRAPHIC 352504
10 GRAPHIC slide3.jpg GRAPHIC 114526
11 GRAPHIC slide4.jpg GRAPHIC 186743
12 GRAPHIC slide5.jpg GRAPHIC 60699
13 GRAPHIC slide6.jpg GRAPHIC 199036
14 GRAPHIC slide7.jpg GRAPHIC 142930
15 GRAPHIC slide8.jpg GRAPHIC 202873
16 GRAPHIC slide9.jpg GRAPHIC 166859
17 GRAPHIC slide10.jpg GRAPHIC 145038
18 GRAPHIC slide11.jpg GRAPHIC 44378
19 GRAPHIC slide12.jpg GRAPHIC 42827
20 GRAPHIC slide13.jpg GRAPHIC 152997
21 GRAPHIC slide14.jpg GRAPHIC 161641
22 GRAPHIC slide15.jpg GRAPHIC 169466
23 GRAPHIC slide16.jpg GRAPHIC 123237
  Complete submission text file 0001193805-24-001257.txt   3604256

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imux-20241022.xsd EX-101.SCH 3003
5 XBRL LABEL FILE imux-20241022_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE imux-20241022_pre.xml EX-101.PRE 22351
34 EXTRACTED XBRL INSTANCE DOCUMENT e663960_8k-immunic_htm.xml XML 3779
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 241384641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)